04-14-2026Price:

The Frontier

Your signal. Your price.

SCIENCE

Doctor urges early fertility testing now

Tuesday, April 14, 2026 · from 1 podcast
  • Get an AMH test at 28, not 35 - $80 could save a decade of planning.
  • Infertility is an early warning sign for heart disease and metabolic decline.
  • Hormone augmentation, not replacement, could protect long-term health.

Fertility isn’t just about babies. According to Dr. Natalie Crawford on the Huberman Lab, it’s a window into a woman’s lifelong health - one that medicine is refusing to open early enough. Current guidelines wait for failure: a year of trying to conceive with no success before testing begins. Crawford calls this policy obsolete, even dangerous. A $79 AMH test can reveal ovarian reserve years before crisis hits - and change everything.

Women are not told that fecundability drops to 3% per month by age 40. Or that 72% of couples conceive in the first six months of trying - but only 13% after that. The data supports earlier intervention, especially for those over 35, yet ACOG still discourages AMH testing outside of clinical infertility. Crawford argues this gatekeeping leaves women blindsided, burning time they can’t recover.

"We should be testing ovarian reserve like we test cholesterol - preventively, not after the heart attack."

- Dr. Natalie Crawford, Huberman Lab

The stakes go beyond fertility. Infertility often signals systemic issues: insulin resistance, autoimmune disease, or chronic inflammation. Microplastics have been found accumulating in ovarian tissue, and endocrine disruptors are linked to lower IVF success. The ovary, Crawford notes, is a canary in the coal mine for metabolic and environmental toxicity.

Hormones aren’t just reproductive signals - they’re protective. Estrogen supports brain health, bone density, and cardiovascular function. Yet doctors wait for full menopause to intervene, using the term 'replacement' as if the system must fully collapse first. Crawford advocates for augmentation: supporting hormone levels earlier, especially in women with low-normal levels and debilitating symptoms.

"Perimenopause can last ten years. We’re telling women to suffer through it as normal aging - that’s medical gaslighting."

- Dr. Natalie Crawford, Huberman Lab

For women who’ve had prior pregnancies - even if lost - some fertility factors are already confirmed: sperm access, tubal patency, uterine receptivity. Yet two losses still trigger full evaluation. Crawford says one complicated loss may warrant earlier testing, including sperm fragmentation and uterine imaging. Egg quality - defined by chromosomal integrity and mitochondrial function - declines with age and metabolic stress. Waiting until 35 or 40 to act ignores the slow burn of oxidative damage.

Source Intelligence

What each podcast actually said

How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie CrawfordApr 13

  • Dr. Natalie Crawford states that fertility is a key health marker. Infertility correlates with higher rates of metabolic syndrome, cancer, heart attack, stroke, and early mortality, often as an early warning sign of chronic inflammation or insulin resistance.
  • Crawford advocates for hormone therapy starting in perimenopause, not just after 12 months without a period. She argues estrogen is cardio-protective, can lower Alzheimer's risk, and protects bone health.
  • Microplastics can accumulate in the ovary and endocrine-disrupting chemicals in plastics are linked to worse IVF outcomes and lower live birth rates in population studies.
  • Crawford cites the Time to Conceive study on natural fertility. Fecundability drops from 20% per month at age 30 to 11-12% at 35, 5% at 38, and 3% at 40+. Having a prior child with the same partner maintains an 18-20% rate until age 37.
  • 72% of people get pregnant in the first six months of trying, and only 13% in the next six months. This is why the infertility testing interval is shortened to six months for those 35 and older.
  • Crawford argues against the standard 'fail first' approach to infertility. She recommends early testing, including semen analysis, ovarian reserve (AMH), and anatomical checks, before a year of trying.
  • A prior pregnancy, even if lost, checks some fertility boxes: it confirms sperm presence, at least one functioning fallopian tube, and some uterine receptivity. The top cause of loss is random genetic abnormality.
  • After two pregnancy losses, Crawford recommends an evaluation including blood tests, semen analysis, sperm fragmentation, and uterine/tubal imaging. This can be moved up to one loss if there were complications.
  • Egg quality refers to genetic normalcy and mitochondrial competency. It declines with age as chromosomes are held in meiosis longer and metabolic health often worsens, increasing oxidative stress and DNA damage.
  • Crawford strongly recommends every woman who may want children get an AMH test, despite ACOG guidelines against it. AMH approximates ovarian reserve (egg quantity), not quality, and costs about $79 out-of-pocket.
  • Tracking ovulation is more informative than just tracking periods. A shortened luteal phase (under 11 days) can be the first sign of an ovulation disorder, even with regular cycles.
  • IVF or egg freezing does not deplete ovarian reserve faster. The process only retrieves the cohort of eggs that would have died that month naturally, not eggs from the primordial 'vault'.
  • Crawford notes political opposition to IVF coverage often stems from ethical debates over embryo disposition. She argues for patient choice and notes workarounds exist, like freezing eggs only.
  • Taking NSAIDs like ibuprofen around ovulation can prevent the follicle from rupturing, inhibiting egg release. Crawford advises limiting them to menstrual periods when trying to conceive.
  • Crawford's five non-negotiables for reducing chronic inflammatory burden and supporting metabolic health are sleep, stress management, muscle (exercise), food, and toxin avoidance.